The growing investment in large-scale research programs and public health biobanks is fueling the need for scalable, tech-driven storage solutions. Automated systems help labs reduce human error, maintain compliance, and support high-throughput workflows, especially in pharmaceutical, biotech, and clinical settings. As sample volumes and data complexity rise, automation is becoming a cornerstone of efficient lab operations, shaping the future of modern laboratory infrastructure and clinical research environments.
In 2024, the automated compound storage systems segment generated USD 721.3 million. These systems play a critical role in pharmaceutical discovery by enabling large-scale chemical library storage with minimal manual intervention. Their ability to streamline compound retrieval and ensure consistency makes them vital to drug screening workflows and pharmaceutical R&D operations. The need for reliable compound management continues to grow due to increasing chemical library sizes and demand for reproducible results in high-throughput environments.
The compound sample segment held a 59.4% share in 2024, driven by rising applications in fast-paced screening environments. As pharmaceutical companies seek faster turnaround times, automated solutions offering precise tracking, temperature control, and robotic handling help enhance compound screening workflows, ultimately reducing timelines and improving efficiency in drug discovery.
U.S. Automated Sample Storage Systems Market generated USD 472.5 million in 2024, solidifying its position as a key regional contributor. North America's leadership stems from a strong presence of pharmaceutical and biotech companies actively using automation in sample storage. The region also hosts major biobank facilities that serve research programs, further boosting demand for scalable and secure sample management systems. The ongoing expansion of drug discovery pipelines and the push for precision medicine are also driving regional adoption of advanced storage solutions.
Leading players shaping the Global Automated Sample Storage Systems Market include Thermo Fisher Scientific, Brooks Automation, MEGAROBO, ASKION, Panasonic Healthcare, TTP LabTech, Biotron Healthcare, SPT Labtech, Beckman Coulter, Haier Biomedical, Angelantoni Life Science, LiCONiC, Azenta, Hamilton Company, and MICRONIC. Key companies in the automated sample storage systems market are focusing heavily on enhancing technology integration, expanding global distribution channels, and developing systems tailored to evolving customer needs. Many are investing in next-gen robotics, AI-based sample tracking, and cloud-based software for seamless connectivity with lab informatics platforms. Companies are also strengthening their regional presence through strategic partnerships and acquisitions, particularly in emerging biopharma hubs.
This product will be delivered within 2-4 business days.
Table of Contents
Companies Mentioned
The companies profiled in this Automated Sample Storage Systems market report include:
- Angelantoni Life Science
- ASKION
- Azenta US
- Beckman Coulter
- Biotron Healthcare
- Brooks Automation
- Haier Biomedical
- Hamilton Company
- LiCONiC
- MEGAROBO
- MICRONIC
- Panasonic Healthcare
- SPT Labtech
- Thermo Fisher Scientific
- TTP LabTech
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 128 |
Published | July 2025 |
Forecast Period | 2024 - 2034 |
Estimated Market Value ( USD | $ 1.3 Billion |
Forecasted Market Value ( USD | $ 3.6 Billion |
Compound Annual Growth Rate | 11.1% |
Regions Covered | Global |
No. of Companies Mentioned | 16 |